4.3 Article

An Augmented Dopamine System Function is Present Prior to Puberty in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia

期刊

DEVELOPMENTAL NEUROBIOLOGY
卷 74, 期 9, 页码 907-917

出版社

WILEY-BLACKWELL
DOI: 10.1002/dneu.22172

关键词

preadolescent; hippocampus; schizophrenia; MAM rat; parvalbumin

资金

  1. NIH [R01: MH090067]
  2. NARSAD award from the Maltz Family Foundation

向作者/读者索取更多资源

Schizophrenia is a disease typically associated with an adolescent onset. Although there have been a considerable number of imaging studies investigating the transition to psychosis in prodromal patients, there are relatively few preclinical studies examining potential mechanisms that may contribute to adolescent onset. We have previously demonstrated, in the methylazoxymethanol acetate (MAM) rodent model of schizophrenia, that an enhanced activity within the ventral hippocampus may underlie the dopamine system hyperfunction, suggested to contribute to positive symptoms in patients. Here we demonstrate that the aberrant regulation of dopamine system function, in MAM-treated rats, is present prior to puberty. Furthermore, we now report that while the afferent regulation of ventral tegmental area dopamine neurons (from the hippocampus and pedunculopontine tegmental area) appears intact in preadolescent rats, the behavioral response to alterations in dopamine system function appears to be attenuated in preadolescent rats. Thus, we posit that the pathological alterations underlying psychosis may be present prior to symptom onset and that the normal development of the postsynaptic side of the dopamine system may underlie the transition to psychosis. (C) 2014 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility

David D. Aguilar, Andrea Giuffrida, Daniel J. Lodge

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

Adiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1

Fengjiao Sun, Yun Lei, Jingjing You, Chen Li, Linshan Sun, Jacob Garza, Di Zhang, Ming Guo, Phillip E. Scherer, Daniel Lodge, Xin-Yun Lu

MOLECULAR PSYCHIATRY (2019)

Article Neurosciences

Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism

Jennifer J. Donegan, Angela M. Boley, Daniel J. Lodge

NEUROPSYCHOPHARMACOLOGY (2018)

Article Psychiatry

Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat

Stephanie M. Perez, Jennifer J. Donegan, Angela M. Boley, David D. Aguilar, Andrea Giuffrida, Daniel J. Lodge

SCHIZOPHRENIA RESEARCH (2019)

Article Behavioral Sciences

Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats

Stephanie M. Perez, Jennifer J. Donegan, Daniel J. Lodge

BEHAVIOURAL BRAIN RESEARCH (2019)

Meeting Abstract Psychiatry

TARGETING HIPPOCAMPAL INTERNEURON FUNCTION AS A THERAPEUTIC APPROACH FOR SCHIZOPHRENIA

Daniel Lodge, Jennifer Donegan

SCHIZOPHRENIA BULLETIN (2019)

Article Multidisciplinary Sciences

Modulation of extrasynaptic GABAA alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner

J. J. Donegan, A. M. Boley, J. Yamaguchi, G. M. Toney, D. J. Lodge

NATURE COMMUNICATIONS (2019)

Article Clinical Neurology

Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility

Stephanie M. Perez, Daniel J. Lodge

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Article Clinical Neurology

Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia

Stephanie M. Perez, Daniel J. Lodge

Summary: The hippocampus and paraventricular nucleus of the thalamus (PVT) play important roles in schizophrenia and may represent potential targets for treatment. The dense expression of orexin receptors in the thalamus suggests they may be a target for regulating PVT activity. Research findings suggest the orexin system may be a novel site for therapeutic intervention in psychosis via action in the PVT.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)

Article Psychiatry

Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis

Hannah B. Elam, Stephanie M. Perez, Jennifer J. Donegan, Daniel J. Lodge

Summary: The orexin system may be a novel pharmacological target for treating comorbid psychosis related to PTSD, reversing increases in dopamine neuron activity and behavioral deficits.

TRANSLATIONAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease

Stephanie M. Perez, Angela M. Boley, Alexandra M. McCoy, Daniel J. Lodge

Summary: Antipsychotics increase the risk of death in elderly patients with Alzheimer's disease (AD). There is a need for new therapies to treat comorbid psychosis in AD. This study used a ferrous amyloid buthionine (FAB) rodent model to investigate the relationship between hippocampal activity and dopamine-dependent psychosis in AD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据